Antibacterial agents: salinamide derivatives
US-9605028-B2 · Mar 28, 2017 · US
Antibacterial agents: salinamide derivatives
US9809626B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9809626-B2 |
| Application number | US-201715436446-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2017 |
| Priority date | Dec 12, 2012 |
| Publication date | Nov 7, 2017 |
| Grant date | Nov 7, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides compounds of formula (I): and salts thereof, wherein X and Y have any of the values defined herein. The compounds inhibit bacterial RNA polymerase, inhibit bacterial growth, and have applications in, analysis of RNA polymerase structure and function, control of bacterial gene expression, control of bacterial growth, antibacterial chemistry, antibacterial therapy, and drug discovery.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for preparing a compound: the method comprising the step of deprotecting a compound: by removing the tert-butyloxycarbonyl (Boc) group. 2. A method for preparing a compound: the method comprising the step of deprotecting a compound: by removing the tert-butyloxycarbonyl (Boc) group. 3. A compound selected from: or a salt thereof.
Assignees
Inventors
Classifications
- C07K11/02Primary
cyclic, e.g. valinomycins {; Derivatives thereof} · CPC title
Antibacterial agents · CPC title
Testing for antimicrobial activity of a material · CPC title
DNA-directed RNA polymerase (2.7.7.6) · CPC title
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9809626B2 cover?
- The invention provides compounds of formula (I): and salts thereof, wherein X and Y have any of the values defined herein. The compounds inhibit bacterial RNA polymerase, inhibit bacterial growth, and have applications in, analysis of RNA polymerase structure and function, control of bacterial gene expression, control of bacterial growth, antibacterial chemistry, anti…
- Who is the assignee on this patent?
- Univ Rutgers
- What technology area does this patent fall under?
- Primary CPC classification C07K11/02. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).